NeoPharm CO. LTD
NeoPharm CO., LTD. manufactures and sells skin care products in South Korea. The company offers Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand; products for sensitive, dry, oily, or trouble-prone skin under the ZEROID brand; body moisturizers under the Derma-B brand; and sport care products for athletes under the MISSION ATHELE… Read more
NeoPharm CO. LTD - Asset Resilience Ratio
NeoPharm CO. LTD (092730) has an Asset Resilience Ratio of 53.07% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2024)
This chart shows how NeoPharm CO. LTD's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down NeoPharm CO. LTD's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩110.05 Billion | 53.07% |
| Total Liquid Assets | ₩110.05 Billion | 53.07% |
Asset Resilience Insights
- Very High Liquidity: NeoPharm CO. LTD maintains exceptional liquid asset reserves at 53.07% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
NeoPharm CO. LTD Industry Peers by Asset Resilience Ratio
Compare NeoPharm CO. LTD's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Globon Co. Ltd
KQ:019660 |
Personal & Household Products & Services | 19.06% |
|
HYUNDAI BIOLAND Co.Ltd
KQ:052260 |
Personal & Household Products & Services | 0.30% |
|
Gentrogroup Co. Ltd.
KQ:083660 |
Personal & Household Products & Services | 19.19% |
|
Nextbike Polska SA
WAR:NXB |
Personal & Household Products & Services | 0.01% |
Annual Asset Resilience Ratio for NeoPharm CO. LTD (2012–2024)
The table below shows the annual Asset Resilience Ratio data for NeoPharm CO. LTD.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 56.27% | ₩108.29 Billion | ₩192.44 Billion | -0.14pp |
| 2023-12-31 | 56.41% | ₩100.11 Billion | ₩177.46 Billion | -16.64pp |
| 2022-12-31 | 73.05% | ₩113.49 Billion | ₩155.35 Billion | -0.20pp |
| 2021-12-31 | 73.25% | ₩105.05 Billion | ₩143.41 Billion | +0.92pp |
| 2020-12-31 | 72.33% | ₩96.18 Billion | ₩132.98 Billion | +2.66pp |
| 2019-12-31 | 69.67% | ₩85.51 Billion | ₩122.74 Billion | +11.50pp |
| 2018-12-31 | 58.17% | ₩42.42 Billion | ₩72.93 Billion | +2.73pp |
| 2017-12-31 | 55.43% | ₩31.43 Billion | ₩56.69 Billion | +5.74pp |
| 2016-12-31 | 49.70% | ₩23.11 Billion | ₩46.51 Billion | +25.38pp |
| 2012-12-31 | 24.32% | ₩8.30 Billion | ₩34.14 Billion | -- |